NF-κB mediates αvβ3 integrin-induced endothelial cell survival

Journal of Cell Biology

Volumn 141, Issue 4, 1998, Pages 1083-1093

  Scatena, Marta ^a   Almeida, Manuela ^a   Chaisson, Michelle L ^a   Fausto, Nelson ^a   Nicosia, Roberto F ^b   Giachelli, Cecilia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA,5BETA,3 INTEGRIN; COLLAGEN TYPE 1; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LAMININ; OSTEOPONTIN; PROTEIN KINASE P13; PROTEIN KINASE P60; RAS PROTEIN; UNCLASSIFIED DRUG; VITRONECTIN; BETA3 INTEGRIN; COLLAGEN; DNA BINDING PROTEIN; FIBRINOGEN RECEPTOR; I KAPPA B; LEUKOCYTE ANTIGEN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; POLYLYSINE; RECOMBINANT PROTEIN; SCLEROPROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, RAT; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL SURVIVAL; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; AORTA; BIOSYNTHESIS; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; KINETICS; MACROMOLECULE; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD; AORTA; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; I-KAPPA B PROTEINS; INTEGRIN BETA3; KINETICS; MACROMOLECULAR SUBSTANCES; NF-KAPPA B; OSTEOPONTIN; PLATELET MEMBRANE GLYCOPROTEINS; POLYLYSINE; RATS; RECEPTORS, VITRONECTIN; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0031596991     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.141.4.1083     Document Type: Article

References (61)

1. Baldwin, A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
2. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:782-784.
3. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
4. Boudreau, N., Z. Werb, and M.J. Bissell. 1996. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA. 93:3509-3513.
5. Brand, K., S. Page, G. Rogler, A. Bartsch, R. Brandl, R. Knuechel, M. Page, C. Kaltschmidt, P.A. Baeuerle, and D. Neumeier. 1996. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1715-1722.
6. Brockman, J.A., D.C. Scherer, T.A. McKinsey, S.M. Hall, X. Qi, W.Y. Lee, and D.W. Ballard. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15:2809-2818.
7. Brooks, P.C., R.A. Clark, and D.A. Chcresh. 1994a. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571.
8. Brooks, P.C., A.M. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier, and D.A. Cheresh. 1994b. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
9. Brooks, P.C., S. Stromblad, R. Klemke, D. Visseher, F.H. Sarkar, and D.A. Cheresh. 1995. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96:1815-1822.
10. Cardone, M.H., G.S. Salvesen, C. Widmann, G. Johnson, and S.M. Frisch. 1997. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell. 9:315-323.
11. Chu, Z.L., T.A. McKinsey, L. Liu, J.J. Gentry, M.H. Malim, and D.W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA. 94:10057-10062.
12. Day, M.L., R.G. Foster, K.C. Day, P. Humphrey, P. Swamson, A.A. Postigo, S.H. Zhang, and D.C. Dean. 1997. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem. 272:8125-8128.
13. Deveraux, O.L., R. Takahashi, G.S. Salvesen, and J.C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
14. Drake, C.J., D.A. Cheresh, and C.D. Little. 1995. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell. Sci. 108:2655-2661.
15. Duttaroy, A., T. Parkes, P. Emtage, K. Kirby, G.L. Boulianne. X.D. Wang. A.J. Hilliker, and J.P. Phillips. 1997. The manganese Superoxide dismutase gene of Drosophila: structure, expression, and evidence for regulation by MAP kinase. DNA Cell Biol. 16:391-399.
16. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science. 271:499-502.
17. Friedlander, M., C.L. Theesfeld, M. Sugita, M. Fruttiger, M.A. Thomas, S. Chang, and D.A. Cheresh. 1996. Involvement of integrins alpha(v)beta(3) and alpha(v)beta(5) in ocular neovascular diseases. Proc. Nutl. Acad. Sci. USA. 93:9764-9769.
18. Frisch, S.M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
19. Frisch, S.M., K. Vuori, D. Kelaita, and S, Sicks. 1996a. A role for Jun-N-Terminal kinase in anoikis: suppression by bcl-2 and crmA. J. Cell Biol. 135:1377-1382.
20. Frisch, S.M., K. Vuori, E. Ruoslahti, and P.Y. ChanHui. 1996b. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134:793-799.
21. Guo, X., Y.P. Zhang, D.A. Mitchell, D.T. Denhardt, and A.F. Chambers. 1995. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol Cell. Biol. 15:476-487.
22. Hoshiga, M., C.E. Alpers, L.L. Smith, C.M. Giachelli, and S.M. Schwartz. 1995. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ. Res. 77:1129-1135.
23. Howlett, A.R., and M.J. Bissell. 1993. The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol. 2:79-89.
24. Hu, S.M., C. Vincenz, J. Ni, R. Gentz, and V.M. Dixit. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J. Biol. Chem. 272:17255-17257.
25. Ingher, D.E., D. Prusty, Z.Q. Sun, H. Betensky, and N. Wang. 1995. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J. Biomech. 28:1471-1484.
26. Irmler, M., M. Thome, M. Hahne, P. Schneider, B. Hofmann, V. Steiner, J.L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature. 388:190-195.
27. Karsan, A., E. Yee, K. Kaushansky, and J.M. Harlan. 1996. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood. 87:3089-3096.
28. Khwaja, A., P. Rodriguez Viciana, S. Wennstrom, P.H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO (Eur. Mol. Biol. Organ.) J. 16:2783-2793.
29. Lee, F.S., J. Hagler, Z.J. Chen, and T. Maniatis. 1997. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:213-222.
30. Lee, K.A., A. Bindereif, and M.R. Green. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5:22-31.
31. Liaw, L., V. Lindner, S.M. Schwartz, A.F. Chambers, and C.M. Giachelli. 1995. Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ. Res. 77:665-672.
32. Lin, C.Q., and M.J. Bissell. 1993. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7:737-743.
33. Lindner, V., and T. Collins. 1996. Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model. Am. J. Pathol. 148:427-438.
34. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565-576.
35. Malinin, N.L., M.P. Boldin, A.V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-kappa B induction by TNF, CD95 and IL-1. Nature. 385:540-544.
36. McGilvray, I.D., Z. Lu, R. Bitar, A.P.B. Dackiw, C.J. Davreux, and O.D. Rotstein. 1997. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J. Biol. Chem. 272:10287-10294.
37. Mercurio, F., H. Zhu, B.W. Murray, A. Shevchenko, B.L. Bennett, J. Li, D.B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 278:860-866.
38. Meredith, J.E., Jr., B. Fazeli, and M.A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:953-961.
39. Nicosia, R.F., S. Villaschi, and M. Smith. 1994. Isolation and characterization of vasolormative endothelial cells from the rat aorta. In Vitro Cell. Der. Biol. Anim. 6:394-399.
40. O'Brien, E.R., M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14:1648-1656.
41. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 78:773-785.
42. Perona, R., S. Montaner, L. Saniger, I. Sánchez-Pérez, R. Bravo, and J.C. Lacal. 1997. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11:463-475.
43. Qwarnstrom, E.E., C.O. Ostberg, G.L. Turk, C.A. Richardson, and K. Bomsztyk. 1994. Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. J. Biol. Chem. 269:30765-30768.
44. Re, F., A. Zanetti, M. Sironi, N. Polentarutti, L. Lanfrancone, E. Dejana, and F. Colotta. 1994. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127:537-546.
45. Rosales, C., and R. Juliano. 1996. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes. Cancer Res. 56:2302-2305.
46. Schaller, M.D., and J.T. Parsons. 1994. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6:705-710.
47. Schlaepfer, D.D., and T. Hunter. 1996. Signal transduction from the extracellular matrix - a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct. Funct. 21:445-450.
48. Schwartz, M.A., M.D. Schaller, and M.H. Ginsberg. 1995. Integrins: emerging paradigms of signal transduction. Ann. Rev. Cell Dev. Biol. 11:549-599.
49. Searle, P.F., G.W. Stuart, and R.D. Palmiter. 1985. Building a metal-responsive promoter with synthetic regulatory elements. Mol. Cell. Biol. 5:1480-1489.
50. Shono, T., M. Ono, H. Izumi, S.I. Jimi, K. Matsushima, T. Okamoto, K. Kohno, and M. Kuwano. 1996. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16:4231-4239.
51. Shu, H.B., D.R. Halpin, and D.V. Goeddel. 1997. Casper is a FADD-and caspase-related inducer of apoptosis. Immunity. 6:751-763.
52. Stoltz, R.A., N.G. Abraham, and M. Laniado Schwartzman. 1996. The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. Proc. Natl. Acad. Sci. USA. 93:2832-2837.
53. Stromblad, S., J.C. Becker, M. Yebra, P.C. Brooks, and D.A. Cheresh. 1996. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J. Clin. Invest. 98:426-433.
54. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen, and V.M. Dixit. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:801-809.
55. Uren, A.G., M. Pakusch, C.J. Hawkins, K.L. Puls, and D.L. Vaux. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated fac-tors. Proc. Natl. Acad. Sci. USA. 93:4974-4978.
56. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274: 787-789.
57. Varner, J.A., and D.A. Cheresh. 1996. Integrins and cancer. Curr. Opin. Cell Biol. 8:724-730.
58. Vermes, I., C. Haanen, H. Steffens Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods. 184:39-51.
59. Wang, C.Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274: 784-787.
60. Wary K.K., F. Mainiero, S.J. Isakoff, E.E. Marcantonio, and F.G. Giancotti. 1996. The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell. 87:733-743.
61. Zhang, Z., K. Vuori, J.C. Reed, and E. Ruoslahti. 1995. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 92:6161-6165.